Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

AeroVironment, Inc. (AVAV), Alliant Techsystems Inc. (ATK), Raytheon Company (RTN): This Military Contractor Has a Secret Weapon

Page 1 of 2

Some people call AeroVironment, Inc. (NASDAQ:AVAV)‘s  Switchblade drone a “Lethal Miniature Aerial Munitions System,” or LMAMS. Others call Switchblade an “agile munitions system” or even “the first smart loitering weapon.” But whatever you want to call it, the U.S. military sure does like the Switchblade — a lot.

Duck and cover — it’s AeroVironment’s Switchblade! Source: AeroVironment.

Contracts galore

AeroVironment, Inc. (NASDAQ:AVAV) describes Switchblade as a “back-packable, non-line-of-sight precision strike solution with minimal collateral effects.” Two feet long and six pounds light, battery-powered, GPS-guided, and remotely piloted, Switchblade can be launched by a soldier in the field, used to identify targets through video streamed by its onboard camera — and then dive-bomb those targets kamikaze-style, detonating its small onboard warhead.

When AeroVironment, Inc. (NASDAQ:AVAV) announced that it had just received a $15.8 million order for its groundbreaking kamikaze drone last month, the military contractor implied that this contract — sizable as it was for a company of AV’s size — might be only the beginning.

AV wasn’t whistling Dixie. Col. Pete Newell, director of the U.S. Army’s Rapid Equipping Force was quoted earlier this year saying that soldiers on the ground in Afghanistan “need dramatically more” Switchblades. And just one week after AV announced its $15.8 million Switchblade contract, the Pentagon confirmed that it had already placed a second order for $6.6 million more — then, a day later, placed another order that was bigger than the first two contracts combined: $29 million.

Launching a Switchblade: Source: AeroVironment

There’s more where that came from

If you’re keeping track at home, that makes $51.4 million in Switchblade orders announced in just the past nine days — nearly 23% of the revenues that AeroVironment, Inc. (NASDAQ:AVAV) collects in a year. All of this is from a new product that AV has barely begun building — and that’s only the beginning of the good news.

The even better news is that because it detonates on impact, each Switchblade used, is a Switchblade “consumed,” and a Switchblade that will need to be replaced.

“Consumable” ordnance like Switchblade is hardly a new concept among military contractors — but it is a profitable one. Every time Alliant Techsystems Inc. (NYSE:ATK) sells the Army a bullet, and the Army fires that bullet, ATK can expect the Army will be ordering a replacement bullet at some time in the future. (Incidentally, Alliant Techsystems Inc. (NYSE:ATK) also makes the warhead for the Switchblade.)

Similarly, and on a much grander revenue scale, every time Raytheon Company (NYSE:RTN) sells the Air Force a rocket, and that rocket gets launched from a Lockheed Martin Corporation (NYSE:LMT) F-35 fighter jet — same story. The military contractor gets to lather, rinse, repeat — and cash another check to pay for the replacement weapon.

That’s a very nice business model compared with, say, that run by Lockheed Martin Corporation (NYSE:LMT) itself, which, once it sells the Air Force an F-35, may have to wait decades for the thing to wear out or become obsolete, so LockMart can sell the Air Force a new one.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!